NASDAQ · Biotechnology

APM (APM) Stock

$0.81 -0.78% NASDAQ: APM Healthcare

Valuation

MetricValue
Price$0.81
Market Cap$5.15M
P/E Ratio-4.42
P/B Ratio0.30
P/S Ratio0.00
EPS (TTM)$-0.19
52-Week High$4.47
52-Week Low$0.65
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-10.79%
ROA-6.52%
ROCE-14.29%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.15
Current Ratio0.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.0M$1.0M$0$0$0
Operating Profit$-19.0M$-18.0M$-11.0M$-4.0M$-2.0M
Net Profit$-25.0M$-10.0M$-3.0M$-4.0M$-1.0M
EPS$-7.15$-2.75$-0.62$-0.78$-0.19
Op Margin-1245.6%-1351.0%-2457.5%——

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$22.0M$21.0M$21.0M$16.0M$19.0M
Total Liabilities$4.0M$13.0M$5.0M$4.0M$5.0M
Cash$8.0M$2.0M$2.0M$1.0M$3.0M
Borrowings$0$7.0M$3.0M$3.0M$4.0M

Latest News

Aptorum Group Provides Update on DiamiR Biosciences Merger GlobeNewswire · Jul 16, 2026 Aptorum Group and DiamiR Biosciences Announce Three Presentations at 2026 Alzheimer’s Association International Conference GlobeNewswire · Jul 8, 2026 Aptorum's Merger Target DiamiR Begins Alzheimer's Biomarker Study With AlzLabs MT Newswires · Jun 22, 2026 Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer’s Disease Biomarkers GlobeNewswire · Jun 22, 2026 Aptorum Shareholders Approve Proposed Merger With DiamiR Biosciences MT Newswires · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-15.0M$-12.0M$-8.0M$-1.0M$-2.0M
Investing Cash Flow$16.0M$2.0M$1.0M$0$0
Financing Cash Flow$1.0M$0$0$0$0
Net Cash Flow$5.0M$-3.0M$-3.0M$-1.0M$3.0M
Free Cash Flow$-15.0M$-13.0M$-8.0M$-1.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA1.53
FCF Yield1.69%
Quick Ratio0.78
Interest Coverage—
Return 1Y-15.68%
Return 3Y-66.20%
Return 5Y-97.10%

Ownership

Institutional HolderSharesReport Date
Citadel Advisors Llc9,2422026-03-31
Susquehanna International Group, LLP1,6782026-03-31
Renaissance Technologies, LLC1,1842026-03-31
Xtx Topco Ltd1,5062026-03-31
Morgan Stanley1,3262026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About APM

APM is led by CEO Chung Yuen Huen, employs 1 people, headquartered in GB, publicly traded since 2018.

APM stock trades at $0.81 with a market capitalization of $5.15M. The stock is valued at a price-to-earnings (P/E) ratio of -4.42, price-to-book of 0.30, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.65 and $4.47, and currently trades 81.9% below its 52-week high.

On profitability, APM generates a return on equity (ROE) of -10.79%, return on capital employed of -14.29%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides